Literature DB >> 9216821

Second primary cancer due to radiotherapy and chemotherapy.

O Manavoğlu1, B Orhan, T Evrensel, Y Karabulut, V Ozkocaman, C Ozyardimci.   

Abstract

Cancer patients are treated successfully with chemotherapy, radiotherapy, or a combination of both. However, many agents used in cancer chemotherapy as well as ionizing radiation are known carcinogens. The long survival of cancer patients treated successfully for their primary cancer made possible the observations of late effects of radiotherapy and chemotherapy and, in particular, the occurrence of second primary cancers. In this report we review the cases of five patients with second primary malignancies and wish to emphasize the importance of a thorough follow-up of patients treated successfully for and possibly cured of a primary cancer.

Entities:  

Mesh:

Year:  1996        PMID: 9216821

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol Oncol        ISSN: 0731-8898            Impact factor:   3.567


  4 in total

1.  Pleomorphic carcinoma of the lung with mediastinal extension following malignant lymphoma: report of a case.

Authors:  Takahiro Nakajima; Toshihiko Iizasa; Akira Iyoda; Kenzo Hiroshima; Kazuhiro Yasufuku; Masako Chiyo; Takashi Anayama; Hidemi Suzuki; Kiyoshi Shibuya; Hidemi Ohwada; Takehiko Fujisawa
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study.

Authors:  Jiayue Ye; Sheng Hu; Wenxiong Zhang; Deyuan Zhang; Yang Zhang; Dongliang Yu; Jinhua Peng; Jianjun Xu; Yiping Wei
Journal:  Front Surg       Date:  2022-05-06

3.  Use of microwave ablation in the treatment of patients with multiple primary malignant tumors.

Authors:  Yue Han; Na Shao; Xiaoming Xi; Xuezhi Hao
Journal:  Thorac Cancer       Date:  2017-05-31       Impact factor: 3.500

4.  Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma.

Authors:  Guoqing Zhang; Bin Wu; Xiaofei Wang; Jindong Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.